We collect cookies to enhance your browsing experience Learn more
The global phentermine hydrochloride market size is evaluated at USD 606.80 million in 2025 and is forecasted to hit around USD 1,115.57 million by 2034, growing at a CAGR of 7.00% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global veterinary antibiotics market size is calculated at USD 5.43 billion in 2025 and is forecasted to reach around USD 7.19 billion by 2034, accelerating at a CAGR of 3.18% from 2025 to 2034. The Asia Pacific market size surpassed USD 2.00 billion in 2024 and is expanding at a CAGR of 3.31% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global complex rehab technology market size is calculated at USD 1 13.09 billion in 2025 and is forecasted to reach around USD 23.76 billion by 2034, accelerating at a CAGR of 6.82% from 2025 to 2034. The North America market size surpassed USD 6.33 billion in 2024 and is expanding at a CAGR of 5.17% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global multiomics market size is calculated at USD 3.24 billion in 2025 and is forecasted to reach around USD 11.79 billion by 2034, accelerating at a CAGR of 15.42% from 2025 to 2034. The North America market size surpassed USD 1.38 billion in 2024 and is expanding at a CAGR of 15.51% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global wegovy market size is calculated at USD 3.07 billion in 2025 and is forecasted to reach around USD 24.53 billion by 2034, accelerating at a CAGR of 25.96% from 2025 to 2034. The North America market size surpassed USD 1.17 billion in 2024 and is expanding at a CAGR of 26.11% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global mounjaro market size is calculated at USD 16.82 billion in 2025 and is forecasted to reach around USD 78.51 billion by 2034, accelerating at a CAGR of 18.67% from 2025 to 2034. The North America market size surpassed USD 10.64 billion in 2024 and is expanding at a CAGR of 18.66% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The cell and gene therapy infrastructure and delivery models market focuses on the systems and models supporting CGT delivery from centralized GMP facilities to point-of-care manufacturing, cold-chain logistics, and clinic integration. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global next-generation biologics market size is calculated at USD 122.24 billion in 2025 and is forecasted to reach around USD 301.22 billion by 2034, accelerating at a CAGR of 10.54% from 2025 to 2034. The North America market size surpassed USD 48.66 billion in 2024 and is expanding at a CAGR of 10.66% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global lipase inhibitors obesity drugs market size is calculated at USD 1.43 billion in 2025 and is forecasted to reach around USD 4.94 billion by 2034, accelerating at a CAGR of 14.72% from 2025 to 2034. The North America market size surpassed USD 487.50 million in 2024 and is expanding at a CAGR of 14.88% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The cell and gene therapy patient access and reimbursement market is expanding with new insurance frameworks, outcome-based payment schemes, and growing demand for personalized, high-cost treatments. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
Gain insights into the ventricular tachycardia (VT) ablation market, with forecasts, regional growth, and key medical device innovations. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global venous leg ulcer market size is calculated at USD 2.57 billion in 2025 and is forecasted to reach around USD 8.47 billion by 2034, accelerating at a CAGR of 14.18% from 2025 to 2034. The North America market size surpassed USD 832.50 million in 2024 and is expanding at a CAGR of 14.33% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global peripheral nerve injury market size is calculated at USD 1.82 billion in 2025 and is forecasted to reach around USD 3.59 billion by 2034, accelerating at a CAGR of 7.84% from 2025 to 2034. The North America market size surpassed USD 591.50 million in 2024 and is expanding at a CAGR of 7.98% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global medical isotope production market size is calculated at USD 4.71 billion in 2025 and is forecasted to reach around USD 9.69 billion by 2034, accelerating at a CAGR of 8.34% from 2025 to 2034. The North America market size surpassed USD 2.52 billion in 2024 and is expanding at a CAGR of 8.45% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The U.S. clinical trial management system market size is calculated at USD 810 million in 2025 and is forecasted to reach around USD 2,400 million by 2034, accelerating at a CAGR of 12.79% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global human biospecimens market size is calculated at USD 13.40 billion in 2025 and is forecasted to reach around USD 26.45 billion by 2034, accelerating at a CAGR of 7.85% from 2025 to 2034. The North America market size surpassed USD 4.97 billion in 2024 and is expanding at a CAGR of 7.98% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The pan-tumor oncology treatment market focuses on therapies effective across multiple tumor types, supported by innovations in molecular diagnostics, immunotherapy, and targeted drug development. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The oncology combination therapy market is expanding due to growing cancer incidence, improved survival rates with synergistic drug combinations, and ongoing innovations in immunotherapy and targeted treatments. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global next-generation cancer therapeutics market size is evaluated at USD 92.54 billion in 2025 and is forecasted to hit around USD 175.20 billion by 2034, growing at a CAGR of 7.35% from 2025 to 2034. The North America market size was accounted at USD 35.34 billion in 2024 and is expanding at a CAGR of 7.48% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The checkpoint inhibitor drugs market is experiencing rapid growth as expanded approval of PD‑1, PD‑L1, and CTLA‑4 inhibitors across multiple cancer types fuels demand, supported by combination therapy strategies, biomarker-driven patient selection, and ongoing clinical trial launches. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
Discover how the single-dose gene therapy market is transforming healthcare with curative therapies for rare and chronic genetic diseases. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The next-gen cardiovascular treatments market is evolving with cutting-edge therapies and tech improving outcomes for cardiovascular patients. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global ventricular tachycardia market size is calculated at USD 15.41 billion in 2025 and is forecasted to reach around USD 24.51 billion by 2034, accelerating at a CAGR of 5.29% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global vacuum blood collection tube market size is calculated at USD 3.16 billion in 2025 and is forecasted to reach around USD 4.22 billion by 2034, accelerating at a CAGR of 3.27% from 2025 to 2034. The North America market size surpassed USD 1.10 billion in 2024 and is expanding at a CAGR of 3.42% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global PCSK9-targeted therapy market size is calculated at USD 11.65 billion in 2025 and is forecasted to reach around USD 28.71 billion by 2034, accelerating at a CAGR of 10.54% from 2025 to 2034. The North America market size surpassed USD 4.85 billion in 2024 and is expanding at a CAGR of 10.66% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
+1 804 441 9344
+61 485 981 310 
sales@precedenceresearch.com